Efficacy of derazantinib in intrahepatic cholangiocarcinoma (iCCA) patients with FGFR2 fusions, mutations or amplifications Meeting Abstract
| Authors: | Borad, M.; Javle, M.; Shaib, W. L.; Mody, K.; Bergamo, F.; Harris, W. P.; Damjanov, N.; Macarulla, T.; Brandi, G.; Masi, G.; Droz Dit Busset, M.; Boncompagni, A.; Dimova-Dobreva, M.; Engelhardt, M.; Saulay, M.; Halfdanarson, T. R.; Knox, J.; Abou-Alfa, G. K.; Personeni, N.; Mazzaferro, V. |
| Abstract Title: | Efficacy of derazantinib in intrahepatic cholangiocarcinoma (iCCA) patients with FGFR2 fusions, mutations or amplifications |
| Meeting Title: | ESMO Congress 2022 |
| Journal Title: | Annals of Oncology |
| Volume: | 33 |
| Issue: | Suppl. 7 |
| Meeting Dates: | 2022 Sep 9-13 |
| Meeting Location: | Paris, France |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2022-09-01 |
| Start Page: | S567 |
| End Page: | S568 |
| Language: | English |
| ACCESSION: | WOS:000866211600059 |
| DOI: | 10.1016/j.annonc.2022.07.087 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 59P -- Source: Wos |
